These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 7834605)

  • 1. Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
    Diaz Romero J; Outschoorn IM
    Clin Microbiol Rev; 1994 Oct; 7(4):559-75. PubMed ID: 7834605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of a group B Neisseria meningitidis vaccine.
    Frasch CE
    Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
    Devi SJ; Zollinger WD; Snoy PJ; Tai JY; Costantini P; Norelli F; Rappuoli R; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1045-52. PubMed ID: 9038314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
    Gandhi A; Balmer P; York LJ
    Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria meningitidis: vaccines and vaccine candidates.
    Al'Aldeen AA; Cartwright KA
    J Infect; 1996 Nov; 33(3):153-7. PubMed ID: 8945702
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
    Pinto VB; Burden R; Wagner A; Moran EE; Lee CH
    PLoS One; 2013; 8(11):e79304. PubMed ID: 24244473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for prevention of meningococcal disease.
    Frasch CE
    Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S134-8. PubMed ID: 2497956
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.
    Moreno C; Lifely MR; Esdaile J
    Infect Immun; 1985 Feb; 47(2):527-33. PubMed ID: 3917979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
    Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
    Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The capsular polysaccharide of serogroup-B meningococci: its immunobiological properties].
    Del'vig AA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):52-6. PubMed ID: 10852023
    [No Abstract]   [Full Text] [Related]  

  • 20. [The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration].
    Basnak'ian IA; Alliluev AP; Kuvakina VI; Aleksakhina NN; Kotel'nikova OV; Chulok TA; Karabak Vi; Borovkova VM; Valerius II; Gofman IL
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):66-7. PubMed ID: 7879546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.